Daniel Meibom

645 total citations
14 papers, 355 citations indexed

About

Daniel Meibom is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel Meibom has authored 14 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Daniel Meibom's work include Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Daniel Meibom is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Daniel Meibom collaborates with scholars based in Germany, Sweden and United States. Daniel Meibom's co-authors include Jan Kihlberg, Vasanthanathan Poongavanam, Anja Giese, Máté Erdélyi, Yoseph Atilaw, Duy Nguyen, Lutz Lehmann, Stephan Siegel, Joachim Mittendorf and Ekkehard Winterfeldt and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Daniel Meibom

14 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Meibom Germany 9 271 121 56 54 31 14 355
Christina R. Majer United States 9 688 2.5× 87 0.7× 69 1.2× 39 0.7× 18 0.6× 13 797
Junfei Cheng China 8 298 1.1× 125 1.0× 68 1.2× 61 1.1× 13 0.4× 12 361
David K. Miyamoto United States 8 320 1.2× 85 0.7× 110 2.0× 24 0.4× 6 0.2× 9 406
Terence C. S. Ho United Kingdom 6 514 1.9× 183 1.5× 127 2.3× 15 0.3× 11 0.4× 11 597
Alex H. Y. Chan United Kingdom 7 531 2.0× 186 1.5× 130 2.3× 15 0.3× 11 0.4× 13 619
Jodie Pang United States 14 267 1.0× 146 1.2× 47 0.8× 42 0.8× 5 0.2× 29 459
Alison E. McGonagle United Kingdom 9 329 1.2× 125 1.0× 181 3.2× 15 0.3× 20 0.6× 11 492
Carolyn A. Weigelt United States 14 255 0.9× 169 1.4× 147 2.6× 20 0.4× 8 0.3× 25 520
Andrea A. Romeo Switzerland 8 228 0.8× 53 0.4× 17 0.3× 21 0.4× 7 0.2× 13 357
Elizabeth Ornelas United States 7 385 1.4× 135 1.1× 94 1.7× 59 1.1× 3 0.1× 9 456

Countries citing papers authored by Daniel Meibom

Since Specialization
Citations

This map shows the geographic impact of Daniel Meibom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Meibom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Meibom more than expected).

Fields of papers citing papers by Daniel Meibom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Meibom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Meibom. The network helps show where Daniel Meibom may publish in the future.

Co-authorship network of co-authors of Daniel Meibom

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Meibom. A scholar is included among the top collaborators of Daniel Meibom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Meibom. Daniel Meibom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Poongavanam, Vasanthanathan, et al.. (2025). Linker-Determined Folding and Hydrophobic Interactions Explain a Major Difference in PROTAC Cell Permeability. ACS Medicinal Chemistry Letters. 16(4). 681–687. 5 indexed citations
2.
Wieske, Lianne H. E., Vasanthanathan Poongavanam, Yoseph Atilaw, et al.. (2024). Impact of Linker Composition on VHL PROTAC Cell Permeability. Journal of Medicinal Chemistry. 68(1). 638–657. 12 indexed citations
3.
Roehrig, Susanne, Eloísa Jiménez Núñez, Katharina Meier, et al.. (2023). Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Journal of Medicinal Chemistry. 66(17). 12203–12224. 14 indexed citations
4.
Meibom, Daniel, Jutta Meyer, Karl D. Collins, et al.. (2023). BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α2B Antagonist. Journal of Medicinal Chemistry. 66(7). 4659–4670. 2 indexed citations
5.
Poongavanam, Vasanthanathan, Anja Giese, Andreas H. Göller, et al.. (2023). Predictive Modeling of PROTAC Cell Permeability with Machine Learning. ACS Omega. 8(6). 5901–5916. 24 indexed citations
6.
Meibom, Daniel, André P. Dieskau, Frank Eitner, et al.. (2022). BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. Journal of Medicinal Chemistry. 65(24). 16420–16431. 7 indexed citations
7.
Poongavanam, Vasanthanathan, Yoseph Atilaw, Stephan Siegel, et al.. (2022). Linker-Dependent Folding Rationalizes PROTAC Cell Permeability. Journal of Medicinal Chemistry. 65(19). 13029–13040. 77 indexed citations
8.
Atilaw, Yoseph, Vasanthanathan Poongavanam, Duy Nguyen, et al.. (2020). Solution Conformations Shed Light on PROTAC Cell Permeability. ACS Medicinal Chemistry Letters. 12(1). 107–114. 117 indexed citations
9.
Härter, Michael, Martina Delbeck, Klemens Lustig, et al.. (2018). Novel non-xanthine antagonist of the A2B adenosine receptor: From HTS hit to lead structure. European Journal of Medicinal Chemistry. 163. 763–778. 11 indexed citations
10.
Meibom, Daniel, Barbara Albrecht‐Küpper, Nicole Diedrichs, et al.. (2017). Neladenoson Bialanate Hydrochloride: A Prodrug of a Partial Adenosine A1 Receptor Agonist for the Chronic Treatment of Heart Diseases. ChemMedChem. 12(10). 728–737. 39 indexed citations
11.
12.
Meibom, Daniel, Marcus Bauser, Heinrich Meier, et al.. (2009). Diversity-Oriented Synthesis of Substituted Pyrazolo[4,3-d][1,2,3]triazin-4-ones. Heterocycles. 78(1). 71–71. 3 indexed citations
13.
Meibom, Daniel, Hilmar Weinmann, & Ekkehard Winterfeldt. (2003). High pressure chiral recognition experiments – a route to homochiral 4-fluorocyclohexenones. ARKIVOC. 2004(2). 4–23. 2 indexed citations
14.
Meibom, Daniel, et al.. (1996). Chiral discrimination in cycloaddition experiments. Chemical Communications. 887–887. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina R. Majer Breakdown of academic impact, for papers by Junfei Cheng Breakdown of academic impact, for papers by David K. Miyamoto Breakdown of academic impact, for papers by Terence C. S. Ho Breakdown of academic impact, for papers by Alex H. Y. Chan Breakdown of academic impact, for papers by Jodie Pang Breakdown of academic impact, for papers by Alison E. McGonagle Breakdown of academic impact, for papers by Carolyn A. Weigelt Breakdown of academic impact, for papers by Andrea A. Romeo Breakdown of academic impact, for papers by Elizabeth Ornelas
Rankless by CCL
2026